Healthcare in Qatar / Doha
Pharmaceutical systems in Qatar / Doha with FDA 21 CFR Part 11 validation gaps, GxP audit trail deficiencies, or computer system validation failures require architecture-level remediation. The UAE PDPL and DIFC compliance posture must be rebuilt in the system, not documented around it.
Pharmaceutical technology lives under FDA 21 CFR Part 11. Data integrity isn't optional — it's existential. Clinical trial data, manufacturing execution, regulatory submissions — every system requires validated, compliant infrastructure.
How We Deliver in Qatar / Doha
UAE & Gulf and Healthcare Frameworks
Healthcare organizations in Qatar / Doha operate under both UAE & Gulf regional frameworks and sector-specific compliance requirements. We embed all applicable frameworks architecturally — not as a parallel compliance workstream running alongside engineering.